PALATINI, PIETRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.923
AS - Asia 2.271
EU - Europa 1.392
AF - Africa 558
SA - Sud America 473
OC - Oceania 57
Continente sconosciuto - Info sul continente non disponibili 27
Totale 11.701
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.630
SG - Singapore 826
CN - Cina 391
HK - Hong Kong 314
BR - Brasile 285
DE - Germania 171
FI - Finlandia 165
VN - Vietnam 158
IT - Italia 119
UA - Ucraina 98
SE - Svezia 84
GB - Regno Unito 79
FR - Francia 73
PL - Polonia 65
RU - Federazione Russa 65
NL - Olanda 44
PK - Pakistan 35
IN - India 29
MX - Messico 28
AE - Emirati Arabi Uniti 27
AR - Argentina 26
BE - Belgio 26
SK - Slovacchia (Repubblica Slovacca) 25
PA - Panama 24
RS - Serbia 24
TN - Tunisia 24
IQ - Iraq 23
TR - Turchia 23
CO - Colombia 22
UZ - Uzbekistan 22
CL - Cile 21
EG - Egitto 21
ID - Indonesia 21
IE - Irlanda 21
SI - Slovenia 21
YT - Mayotte 21
AO - Angola 20
BO - Bolivia 20
EC - Ecuador 20
JO - Giordania 20
SN - Senegal 20
YE - Yemen 20
LB - Libano 19
NP - Nepal 19
PT - Portogallo 19
PY - Paraguay 19
TT - Trinidad e Tobago 19
CR - Costa Rica 18
CV - Capo Verde 18
IR - Iran 18
AL - Albania 17
BW - Botswana 17
CI - Costa d'Avorio 17
GT - Guatemala 17
KR - Corea 17
KZ - Kazakistan 17
LU - Lussemburgo 17
ML - Mali 17
MU - Mauritius 17
PH - Filippine 17
PS - Palestinian Territory 17
UY - Uruguay 17
ZA - Sudafrica 17
BY - Bielorussia 16
CH - Svizzera 16
CZ - Repubblica Ceca 16
DK - Danimarca 16
EE - Estonia 16
GE - Georgia 16
GF - Guiana Francese 16
GP - Guadalupe 16
GR - Grecia 16
KG - Kirghizistan 16
LY - Libia 16
MK - Macedonia 16
MY - Malesia 16
SA - Arabia Saudita 16
TH - Thailandia 16
VE - Venezuela 16
AF - Afghanistan, Repubblica islamica di 15
BB - Barbados 15
CY - Cipro 15
DJ - Gibuti 15
DZ - Algeria 15
ET - Etiopia 15
KH - Cambogia 15
NC - Nuova Caledonia 15
AM - Armenia 14
BJ - Benin 14
CD - Congo 14
CG - Congo 14
DO - Repubblica Dominicana 14
HR - Croazia 14
MZ - Mozambico 14
NE - Niger 14
NO - Norvegia 14
RO - Romania 14
RW - Ruanda 14
XK - ???statistics.table.value.countryCode.XK??? 14
AZ - Azerbaigian 13
Totale 11.098
Salva come PNG Salva come JPEG
Città #
Fairfield 881
Woodbridge 776
Ann Arbor 648
Houston 552
Chandler 482
Singapore 472
Ashburn 461
Jacksonville 374
Wilmington 306
Hong Kong 293
Seattle 284
Cambridge 276
Santa Clara 169
Princeton 157
Boardman 138
Beijing 90
San Diego 88
Roxbury 83
Nanjing 64
Medford 54
Dong Ket 52
Helsinki 50
Padova 49
Ho Chi Minh City 47
Bytom 46
Des Moines 40
Munich 39
Shenyang 31
New York 26
Los Angeles 24
Nanchang 23
Panama City 23
Chicago 22
Dakar 20
Hanoi 20
Tianjin 20
Tashkent 19
Amman 18
Abidjan 17
Bamako 17
Hebei 17
São Paulo 17
Dublin 16
London 16
Norwalk 16
Bishkek 15
Bridgetown 15
Jinan 15
Ljubljana 15
Luanda 15
Noumea 15
Phnom Penh 15
Guangzhou 14
Guatemala City 14
Kigali 14
Montevideo 14
Praia 14
Cotonou 13
Maputo 13
Niamey 13
San José 13
Accra 12
Conakry 12
Djibouti 12
Gaborone 12
Havana 12
Kampala 12
Kinshasa 12
Libreville 12
Luxembourg 12
Managua 12
Pristina 12
Salt Lake City 12
Tripoli 12
Turku 12
Yerevan 12
Athens 11
Bangkok 11
Castries 11
Dushanbe 11
Hefei 11
Mamoudzou 11
Reykjavik 11
Rio de Janeiro 11
Tallinn 11
Tirana 11
Zurich 11
Addis Ababa 10
Baku 10
Banjul 10
Buffalo 10
Kuala Lumpur 10
Les Abymes 10
Lusaka 10
Rawalpindi 10
Sanaa 10
Ulan Bator 10
Aden 9
Baghdad 9
Belgrade 9
Totale 7.988
Salva come PNG Salva come JPEG
Nome #
Severe Liver Cirrhosis Markedly Reduces AhR-Mediated Induction of Cytochrome P450 in Rats by Decreasing the Transcription of Target Genes 220
Biological and pharmacological properties of phospholipids. 211
In vitro hepatic conversion of the anticancer agent nemorubicin to its active metabolite PNU-159682 in mice, rats and dogs: A comparison with human liver microsomes 202
Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes 191
Expression and distribution of the adrenomedullin system in newborn human thymus. 187
A comparison between different methods for the determination of reduced and oxidized glutathione in mammalian tissues 183
Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitro. 183
Coadministration of sirolimus alters tacrolimus pharmacokinetics. 180
An intracellular adrenomedullin system reduces IL-6 release via a NF-kB-mediated, cAMP-independent transcriptional mechanism in rat thymic epithelial cells 177
Effect of age on single- and multiple-dose pharmacokinetics of erythromycin 162
Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis 162
Diagnostic value of plasma cystatin C as a glomerular filtration marker in decompensated liver cirrhosis 161
Enzyme inhibition and induction in liver disease. 161
Pharmacokinetic drug interactions in liver disease: An update 160
Differential effect of liver cirrhosis on the pregnane X receptor-mediated induction of CYP3A1 and 3A2 in the rat. 157
Effect of herpes simplex virus type 1 infection on nucleoside transport in HeLa S3 cells 157
Inhibition of cytochrome P450 2C8-mediated drug metabolism by the flavonoid diosmetin. 155
Penetration of carumonam into the pleural fluid: comparison of intravenous bolus and constant infusion in rats with experimentally induced pleurisy. 154
Further purification and characterization of the succinyl-CoA:3-hydroxy-3-methylglutarate coenzyme A transferase from rat-liver mitochondria. 150
Synergism between lysophosphatidylserine and the phorbol ester tetradecanoylphorbolacetate in rat mast cells. 147
A reassessment of the optimal sampling time for the MEGX liver function test 147
The effect of liver disease on inhibitory and plasma protein-binding displacement interaction:an update. 146
Co-administration of sirolimus alters tacrolimus pharmacokinetics in a dose-dependent manner in adult renal transplant recipients 146
Fluvoxamine pharmacokinetics in healthy elderly subjects and elderly patients with chronic heart failure 143
A Comparative Analysis of the Urinary Excretion Profiles of Mesna and Argimesna Following Oral Administration to Healthy Volunteers 142
Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: effects of liver function 141
Pharmacokinetic characterization of phosphatidylserine liposomes in the rat 139
Pharmacokinetics of intraperitoneal cisplatin and doxorubicin 138
Neoral versus Sandimmun in kidney-pancreas transplantation 137
Reactivation of a phospholipid-depleted sodium, potassium-stimulated ATPase. 136
Irreversible CYP3A Inhibition Accompained by Plasma Protein-Binding Displacement: A Comparative Analysis in Subjects with normal and impaired liver function. 135
The role of residual phospholipids and copurified proteins in the reconstitution of bovine heart mitochondrial ATPase complex. 134
Effects of single dose of gamma-hydroxybutyric acid and lorazepam in psychomotor performance and subjective feelings in healthy volunteers 133
Disposition kinetics of phospholipid liposomes. 133
The effect of age on plasma MEGX concentrations. 132
Canrenone as a partial agonist at the digitalis receptor site of (Na+-K+)ATPase 131
Differential inducing effect of benzo[a]pyrene on gene expression and enzyme activity of cytochromes P450 1A1 and 1A2 in Sprague-Dawley and Wistar rats. 130
Mechanism of local anesthetic effect. Involvement of F0 in the inhibition of mitochondrial ATP synthase by phenothiazines. 129
Influence of the mode of intravenous administration on the penetration of ceftazidime into tissues and pleural exudate of rats. 128
Oral administration of trans-resveratrol to guinea pigs increases cardiac DT-diaphorase and catalase activities, and protects isolated atria from menadione toxicity 127
Liver dysfunction markedly decreases the inhibition of cytochrome P450IA2-mediated theophylline metabolism by fluvoxamine 126
Role of antioxidant defences in the species-specific response of isolated atria to menadione 124
Enzyme induction is independent on liver functional status 123
Effect of gender on the monoethylglycinexylidide test in healthy subjects and patients with liver cirrhosis 123
F1-ATPase from different submitochondrial particles. 123
Hyperthermic intraoperative intraperitoneal chemotherapy with cisplatin and doxorubicin in patients who undergo cytoreductive surgery for peritoneal carcinomatosis and sarcomatosis - Phase I study 123
Liver dysfunction markedly decreases the inhibition of CYP1A2-mediated theophylline metabolism by fluvoxamine 121
The pharmacokinetics of teniloxazine in healthy subjects and patients with liver cirrhosis 120
EFFECTS OF HERPES-SIMPLEX VIRUS TYPE-1 INFECTION ON THE PLASMA- MEMBRANE AND RELATED FUNCTIONS OF HELA S3 CELLS 120
Mechanism of Na+/K(+)-ATPase activation by trypsin and kallikrein. 119
Effect of renal flailure on metabolic disposition of lidocaine in patients undergoing and not undergoing hemodialysis 118
Protective action of cardiac DT-diaphorase against menadione toxicity in guinea pig isolated atria 118
Oral disposition kinetics of ofloxacin in patients with compensated liver cirrhosis. 117
Dose-dependent absorption and elimination of gamma-hydroxybutyric acid in healthy volunteers. 116
Role of phosphatidylserine and phosphatidylcholine in the dicyclohexylcarbodiimide-induced inhibition of mitochondrial ATPase. 116
Nephrotoxic effect of atractyloside in rats. 116
Renal clearance of N(1)-methylnicotinamide: a sensitive marker of the severity of liver dysfunction in cirrhosis 115
Apomorphine-induced inhibition of histamine release in rat peritoneal mast cells. 115
Pharmacokinetics of gamma-hydroxybutyric acid in alcohol dependent patients after single and repeated oral doses. 115
Absorption and disposition kinetics of flunoxaprofen and benoxaprofen in healthy volunteers. 113
Reduction of erythrocyte (Na+-K+)ATPase activity in type 1 (insulin-dependent) diabetic subjects and its activation by homologous plasma. 112
The interaction of tricyclic antipsychotics with (Na+-K+)ATPase 110
Inhibition of protein kinase activity by apomorphine. 108
Renal clearance of N-1-Methylnicotinamide is a marker of liver dysfunction in cirrhosis 107
Pharmacokinetics of miocamycin in patients with liver cirrhosis. 107
Reversal by phospholipids of the oligomycin induced inhibition of membrane associated adenosintriphosphatases. 107
Mechanism of inhibition of sodium- and potassium-dependent adenosine triphosphatase by tricyclic antipsychotics 105
A new plot for multiple enzyme inhibition 105
Mechanism of local anesthetic effect on mitochondrial ATP synthase as deduced from photolabelling and inhibition studies with phenothiazine derivatives. 105
Anion activation of dopamine beta-hydroxylase: a kinetic model. 102
Needle and trocar injuries in diagnostic laparoscopy under local anesthesia: what is the true incidence of these complications? 96
[Function of phospholipids in a membranous in a membranous complex with ATPase activity]. 96
Kinetic studies with competitive inhibitors indicate a sequential mechanism for dopamine beta-hydroxylase. 96
In vitro inhibition of cytochrome P450 (CYP) 2C8-mediated drug metabolism by the flavonoid diosmetin 95
A simple method for discriminating between full and partial inhibitors 94
Effects of chronic renal failure and hemodialysis on the monoethylglycinexylidide liver function test. 93
Fumarate is the cause of the apparent ping-pong kinetics of dopamine beta-hydroxylase. 92
Mg-dependent inhibition of beef heart soluble mitochondrial ATPase by tricyclic antipsychotics 90
The interaction between full and partial inhibitors acting on a single enzyme: a theoretical analysis 89
Evaluation of measured and calculated creatinine clearances as glomerular filtration markers in different stages of liver cirrhosis 86
Evaluation ciprofloxacin and ofloxacin pharmacokinetics in liver cirrhosis. 84
Effect of experimentally induced liver cirrhosis on CYP3A induction in male Wistar rats 81
Pharmacokinetic interactions between Tacrolimus and Sirolimus in Kidney Transplant recipients 81
Differential effect of liver dysfunction on CYP3A1 and CYP3A2 expression in rats with carbon tetrachloride-induced cirrhosis 79
Interazioni farmacocinetiche tra Tacrolimus e Sirolimus nel Trapianto Renale 79
Stereospecific disposition of flunoxaprofen enantiomers in human beings. 78
Inhibition of dopamine beta-hydroxylase by captopril. 76
ORAL DISPOSITION KINETICS OF N-(AMINOSULPHONYL)-3-(((DIAMINOETHYLENE) AMINO)-N-THIAZOLYL) METHYLTHIOPROPANIMIDAMIDE (FAMOTIDINE) IN PATIENTS WITH LIVER-CIRRHOSIS 76
Effect of CYP 3A4 inhibition on lidocaine kinetics and the MEGS liver function test 75
Serine phospholipids as endocoids. 69
Pharmacokinetics of gamma hydroxybutyric acid. 66
Effect of liver functional status on the pharmacokinetic interaction between the CYP 1A2 inhibitor fluvoxamine and lidocaine 65
Famotidine pharmacokinetics in the elderly: results of a preliminary study 64
Effect of moderate or severe liver dysfunction on the pharmacokinetics of gamma-hydroxybutyric acid 61
The behaviour of miocamycin kinetics in cirrhotic patients after single and repeated oral administration. 61
Inhibition of enzymes and enzyme by phenothiazines and their radicals. In: Phenothiazienes and 1,4-benzothiazines 61
Totale 11.719
Salva come PNG Salva come JPEG
Categoria #
all - tutte 35.692
article - articoli 33.051
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 177
Totale 68.920
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021622 0 0 0 0 25 87 46 89 126 61 95 93
2021/20221.132 35 124 138 87 29 77 48 124 42 36 130 262
2022/2023951 177 132 11 103 166 137 10 59 108 6 30 12
2023/2024326 22 57 36 32 18 30 8 22 6 2 47 46
2024/20251.758 3 146 71 70 293 44 47 119 160 73 307 425
2025/20263.077 200 567 914 1.091 305 0 0 0 0 0 0 0
Totale 11.719